Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
BMS-986460 by Bristol-Myers Squibb for Metastatic Castration-Resistant Prostate Cancer (mCRPC): Likelihood of Approval
BMS-986460 is under clinical development by Bristol-Myers Squibb and currently in Phase I for Metastatic Castration-Resistant Prostate Cancer (mCRPC). According...